LQDA FY 2023 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+9.7% YoY

Gross Profit

$15M83.5% margin

Operating Income

-$73M-419.6% margin

Net Income

-$79M-448.9% margin

EPS (Diluted)

$-1.21

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$43M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$118M

Total Liabilities

$71M

Stockholders' Equity

$47M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$16M	+9.7%
Gross Profit	$15M	$13M	+11.7%
Operating Income	-$73M	-$39M	-89.3%
Net Income	-$79M	-$41M	-91.4%